Devices part of US price transparency initiative
This article was originally published in Clinica
The US federal health programmes soon will begin disclosing how much doctors and hospitals charge for 20 common medical procedures, Health and Human Services (HHS) secretary Mike Leavitt announced last week.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.